Skip to Main Content

Paper Details

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030.
medRxiv
0
2023
Circulating, Circulating tumor DNA, MAESTRO, NAT, RCB, RCB-2, RCB-3, TBCRC, TFx, TNBC, cancer, circulating tumor DNA, cisplatin, ctDNA, paclitaxel, patients, plasma, triple-negative breast cancer
Author NameAffiliation
Lisa A CareyThe University of North Carolina Lineberger Comprehensive Cancer Center
Mothaffar F RimawiBaylor College of Medicine Dan L. Duncan Comprehensive Cancer Center
Vered StearnsJohns Hopkins Sidney Kimmel Comprehensive Cancer Center
Antonio C WolffJohns Hopkins Sidney Kimmel Comprehensive Cancer Center
Eric P WinerDana-Farber Cancer Institute
Eric P WinerDana-Farber Brigham Cancer Center
Eric P WinerHarvard Medical School
Ian E KropDana-Farber Cancer Institute
Ian E KropHarvard Medical School
Ian E KropDana-Farber Brigham Cancer Center
Todd R GolubBroad Institute of MIT and Harvard
Todd R GolubBroad Institute of MIT and Harvard
  • 1 - 12

Datasets

Release 1.2